24 min listen
Why Patients Can (and Should) Become Researchers, Discussion With Dr. Helen Dimaras
Why Patients Can (and Should) Become Researchers, Discussion With Dr. Helen Dimaras
ratings:
Length:
36 minutes
Released:
Apr 11, 2021
Format:
Podcast episode
Description
Dr. Helen Dimaras discusses how empowering Retinoblastoma survivors and their families to have a greater role in the decision-making process of research projects has led to more inclusive, high-quality, and translatable results. The Canadian Retinoblastoma Research Advisory Board (CRRAB) is co-directed by patients, clinicians, allied healthcare providers, researchers, patient engagement experts, and policymakers.
Released:
Apr 11, 2021
Format:
Podcast episode
Titles in the series (74)
TapTapSee: Leveraging Technology To Help the Low Vision Community - Brad Folkens: Brad Folkens, CEO of TapTapSee, explains how the application helps people who are blind or have low vision “see“ using their smart phones. Brad covers the origins of the company and its technology, common use cases, and how the technology can be impr... by BroadEye: An Ophthalmology Podcast